| 1 | ASCO | 2.76% | |
| 2 | Therapy | 2.21% | |
| 3 | Cell | 2.21% | |
| 4 | Cancer | 1.66% | |
| 5 | Patients | 1.66% | |
| 6 | Surgery | 1.1% | |
| 7 | Study | 1.1% | |
| 8 | Receptor | 1.1% | |
| 9 | Triggered | 1.1% | |
| 10 | Report | 1.1% | |
| 11 | Annual | 1.1% | |
| 12 | Against | 1.1% | |
| 13 | Human | 1.1% | |
| 14 | Bronchiolitis | 0.55% | |
| 15 | Clinical | 0.55% | |
| 16 | Clear | 0.55% | |
| 17 | Carry | 0.55% | |
| 18 | Trimodality | 0.55% | |
| 19 | Strategies | 0.55% | |
| 20 | Constant | 0.55% | |
| 21 | Dosages | 0.55% | |
| 22 | Proteins | 0.55% | |
| 23 | Effectiveness | 0.55% | |
| 24 | Risk | 0.55% | |
| 25 | (R/R) | 0.55% | |
| 26 | Boost | 0.55% | |
| 27 | Syndrome | 0.55% | |
| 28 | Biomarkers | 0.55% | |
| 29 | Need | 0.55% | |
| 30 | Hemophagocytic | 0.55% | |
| 31 | Antigen | 0.55% | |
| 32 | Armored | 0.55% | |
| 33 | Servings | 0.55% | |
| 34 | Could | 0.55% | |
| 35 | Pathogens | 0.55% | |
| 36 | Berries | 0.55% | |
| 37 | Chief | 0.55% | |
| 38 | Carcinoma | 0.55% | |
| 39 | Woman | 0.55% | |
| 40 | Freedom | 0.55% | |
| 41 | Utility | 0.55% | |
| 42 | Muscle | 0.55% | |
| 43 | Day | 0.55% | |
| 44 | Multiple | 0.55% | |
| 45 | Refractory | 0.55% | |
| 46 | Renal | 0.55% | |
| 47 | Invasive | 0.55% | |
| 48 | Trials | 0.55% | |
| 49 | Progression | 0.55% | |
| 50 | Meeting | 0.55% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||